Fig. 3

Outcome of patients according to the Cre-LiMAx risk score values measured on evaluation day. Medians are indicated by bold lines, the range from lower to upper quartile by boxes, 1.5 interquartile range by whiskers and outliers by circles. The cut-off (≤0.9points) is indicated by a bold dotted horizontal line. Differences between survivors and non-survivors were 0.91 (±0.1) and 0.66 (±0.27) points (p = 0.007) for 3-month survival; 0.91 (±0.1) and 0.74 (±0.24) points (p = 0.037) for 6-month survival and 0.91 (±0.1) and 0.81 (±0.19) points (p = 0.117) for 12-month survival (patients with unclear and non-liver-related death [n = 4] were censored), respectively.